DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/md5m3k/us_diabetes) has announced the addition of the "US Diabetes Market Outlook 2020" report to their offering.
Diabetes has been on the rise for the last few years because of factors such as increased life span of people, hectic lifestyles and increased intake of fatty food. The largest number of cases of diabetes and pre-diabetes are found in the United States, with many still unaware about their diabetes or pre-diabetes condition. It has been estimated that the prevalence of diabetes will be 14% by 2030 in the US. This is likely to put a major burden on the healthcare cost of the country. Studies have shown that the total healthcare expenditure in US was US$ 281 Billion in 2014 which was the largest share of the world healthcare expenditure.
The US diabetes care market is segmented into three parts, namely- anti-diabetic drugs segment, insulin delivery devices segment and monitoring and diagnostic devices segment. The most significant growth in the US market has been seen in continuous blood glucose meters, insulin pens, insulin pumps, and anti-diabetic drugs.
The report, US Diabetes Market Outlook 2020, highlights the US diabetes market by each segment. The market for each segment has been thoroughly studied and the future market scenario has been forecasted. The prevalence of diabetes and its cost implications have also been indicated in the report. The drivers and challenges of this market have been discussed along with the latest trends and developments. Additionally, information is provided about the key players in this market as well as the steps taken by the government to promote the market. The aforementioned information will help clients in formulating strategies and assessing opportunities in the US diabetes market.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Market Overview
4. Patient Profile Analysis
5. Cost Implications
6. Drivers and Challenges
7. Diabetes Drugs Market
8. Insulin Delivery Devices Market
9. Glucose Monitoring Devices Market
10. Trends and Developments
11. Government Initiatives
12. Competitive Landscape
- Abbott Laboratories
- Bayer
- Eli Lilly
- GlaxoSmithKline
- Medtronic Inc.
- Merck
- Novo Nordisk
- Pfizer
- Roche
- Sanofi
- Takeda
For more information visit http://www.researchandmarkets.com/research/md5m3k/us_diabetes
